Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -109.11M | -112.66M | -117.98M | -123.4M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Depreciation & Amortization | 21.71K | 21.59K | 22.32K | 21.88K | 17.88K | 12.8K | 7.05K | -319 | 59.62K | 123.09K | 186.44K | 254.82K | 262.9K | 259.44K | 271.68K | 262.58K | 249.82K | 237.84K |
Stock-Based Compensation | 530.48K | 522.24K | 489.44K | 446.27K | 373.21K | 514.04K | 444.46K | 418.95K | 381.16K | 14.91M | 16.98M | 19.02M | 21.01M | 8.08M | 7.81M | 7.15M | 6.51M | 5.9M |
Other Working Capital | 273.06K | 287.67K | -721.25K | -1.04M | -836.31K | -1.37M | -538.31K | -684.28K | -1.62M | -1.1M | -900.07K | -3.26M | -4.57M | -3.2M | -5.6M | -2.48M | -920.8K | -1.24M |
Other Non-Cash Items | 73.98K | 136.26K | 28.28K | -723.92K | -603.55K | -748.06K | -678.09K | 146.9K | -33.32K | 72.39M | 72.24M | 72.14M | 72.18M | 68.37K | -317.4K | 926.65K | 979.31K | 2.62M |
Deferred Income Tax | n/a | n/a | n/a | 709.2K | 709.2K | 709.2K | 709.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 482.79K | 251.78K | -1.04M | -752.71K | -995.96K | -876.02K | 1.66M | 414.64K | -3.11M | -817.97K | -1.76M | -4.6M | -2.87M | -4.67M | -8.33M | -4.29M | -4M | -789.96K |
Operating Cash Flow | -12.74M | -13.15M | -13.45M | -13.81M | -13.43M | -13.1M | -12.15M | -12.31M | -16.81M | -22.49M | -25.01M | -31.17M | -32.81M | -31.66M | -37.69M | -40.71M | -43.9M | -45.78M |
Capital Expenditures | 171.49 | -7.12K | -15.1K | -24.04K | -107.91K | -100.61K | -92.64K | -84.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.29K | -15.56K | -13.54K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 175.41 | -7.11K | -15.09K | -24.04K | -107.91K | -75.77K | -67.8K | -59.24K | 24.84K | n/a | n/a | n/a | n/a | n/a | n/a | -16.29K | -15.56K | -13.54K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -310.12K | -287.2K | -1.58M | -1.57M | -1.29M | -1.31M | -673.77K | -673.77K | -673.77K | -648.93K | n/a | 1.66M | 1.75M | 1.75M | 1.75M | -63.98K | -141.81K | -20.38K |
Financial Cash Flow | 573.98K | -30.82K | 14.62M | 14.58M | 14.49M | 14.68M | 5.11M | 5.13M | 5.8M | 5.82M | 682.97K | 2.24M | 1.75M | 1.75M | 1.75M | 86.97K | n/a | 121.43K |
Net Cash Flow | -12.16M | -13.1M | 1.24M | 896.39K | 1.01M | 1.41M | -7.14M | -7.72M | -11.34M | -16.66M | -24.29M | -28.32M | -30.74M | -29.96M | -35.94M | -39.72M | -43.06M | -44.9M |
Free Cash Flow | -12.74M | -13.16M | -13.47M | -13.83M | -13.69M | -13.36M | -12.39M | -12.54M | -16.81M | -22.49M | -25.01M | -31.17M | -32.81M | -31.66M | -37.69M | -40.72M | -43.91M | -45.8M |